Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.
<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methyl...
Guardado en:
Autores principales: | Ibrahim Musa Yola, Carlee Moser, Meredith S Duncan, Edzard Schwedhelm, Dorothee Atzler, Renke Maas, Juliane Hannemann, Rainer H Böger, Ramachandran S Vasan, Vanessa Xanthakis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ceb4479eea9640919734a6f24a35e397 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients
por: Juliane Hannemann, et al.
Publicado: (2021) -
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: S. Tommasi, et al.
Publicado: (2017) -
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Gian Luca Erre, et al.
Publicado: (2019) -
Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
por: Gąsecka A, et al.
Publicado: (2021) -
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
por: Francesco Andreozzi, et al.
Publicado: (2012)